https://www.selleckchem.com/pr....oducts/Staurosporine
PPM implantation for HAVB or CHB occurred in 234 patients (16%) within 30days after TAVR. The incidence of PPM implantation was 2.7% in the early discharge group, 41% in the group with higher risk for HAVB or CHB, and 100% in the PPM group. The 2019 consensus algorithm safely identifies patients with no need for PPM implantation. This strategy allows more uniform management of TAVR patients and facilitates early discharge of low-risk patients without prolonged monitoring in 3 of 4 patients. However, the algorithm is less precise i
Me gusta
Comentario
Compartir
